Search
Kiniksa Pharmaceuticals International PLC
KNSAAdd to Watchlist
76.280USD
-1.720-2.21%
Market hours 09/23, 11:08（ET）
5.95BMarket Cap
78.40P/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.21%
5 Days
+1.50%
1 Month
-3.48%
6 Months
+65.54%
Year to Date
+84.92%
1 Year
+111.42%
Key Figures
77.725Open
79.540High
5.02KVolume
78.40P/E TTM
35.72P/E Dynamic
--Dividend TTM
0.01%Turnover Ratio
78.000Prev. Close
76.250Low
386.90KTurnover
LossP/E Static
9.10P/B
0.00%Div Yield TTM
10.26%ROA
82.94052wk High
0.03Volume Ratio
-43.19MNet Profit
78.02MShares
0.9729EPS TTM
0.14Beta
13.74%ROE
35.20052wk Low
4.22%Amplitude
90.31%Gross Margin
5.95BMarket Cap
9.20Reward/Risk
3.15%Risk Rate
More news coming soon, stay tuned...
Kiniksa Pharmaceuticals International PLC's Score
-0.03vs previous score
Forecast8.75
Financial Health9.21
Technical2.78
Valuation Dimensions7.10
Institutional Confidence10.00
Risk Assessment7.36
Media Coverage
Coverage Level
Very Low
Very High
Neutral
Analyst Rating
Kiniksa Pharmaceuticals International PLC Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
0.33/0.30
Revenue / Forecast
243.60M/225.46M
Kiniksa Pharmaceuticals International PLC Profile
SectorPharmaceuticals
Ticker SymbolKNSA
Number of employees315
CountryUnited Kingdom
Ownership
| Shareholders | Proportion |
|---|---|
| Fidelity Management & Research Company LLC | 10.48% |
| Rubric Capital Management LP | 7.19% |
| Baker Bros. Advisors LP | 6.10% |
| Tang Capital Management, LLC | 4.88% |
| Shareholder Types | Proportion |
|---|---|
| Hedge Fund | 37.95% |
| Investment Advisor | 30.61% |
| Investment Advisor/Hedge Fund | 27.20% |
| Research Firm | 6.68% |
Related Instruments
-0.83%
+0.24%
+0.36%
-1.84%
+0.88%
-1.59%
-0.37%
-0.44%
-2.30%
+0.14%
-0.08%
-0.92%
+0.51%
-0.89%
-2.02%
-0.92%
+0.87%
-0.40%
-1.22%
+0.99%Popular Instruments
51709.400
-141.600 (-0.27%)
30515.800
-185.400 (-0.60%)
7729.200
-31.500 (-0.41%)
14437.000
-202.000 (-1.38%)
66363.000
-659.000 (-0.98%)
6304.900
-40.900 (-0.65%)
91.090
+1.381 (+1.54%)
337.940
-1.810 (-0.53%)
226.240
-2.630 (-1.15%)
4294.260
-62.950 (-1.45%)
FAQs
What is the current price of Kiniksa Pharmaceuticals International PLC (KNSA)?
The current price of Kiniksa Pharmaceuticals International PLC (KNSA) is 78.00.
What is the symbol of Kiniksa Pharmaceuticals International PLC?
The ticker symbol of Kiniksa Pharmaceuticals International PLC is KNSA.
What is the 52-week high of Kiniksa Pharmaceuticals International PLC?
The 52-week high of Kiniksa Pharmaceuticals International PLC is 82.94.
What is the 52-week low of Kiniksa Pharmaceuticals International PLC?
The 52-week low of Kiniksa Pharmaceuticals International PLC is 35.20.
What is the market capitalization of Kiniksa Pharmaceuticals International PLC?
The market capitalization of Kiniksa Pharmaceuticals International PLC is 6.09B.
Is Kiniksa Pharmaceuticals International PLC (KNSA) currently rated as Buy, Hold, or Sell?
According to analysts, Kiniksa Pharmaceuticals International PLC (KNSA) has an overall rating of Buy, with a price target of 96.71.
What is the Earnings Per Share (EPS TTM) of Kiniksa Pharmaceuticals International PLC (KNSA)?
The Earnings Per Share (EPS TTM) of Kiniksa Pharmaceuticals International PLC (KNSA) is 0.97.